arrow
S

Steven E. Kahn

university of washington
H指数:123
被引数:7.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Human islet amyloid polypeptide aggregation upregulates the mitochondrial cholesterol transport protein StAR and induces mitochondrial dysfunction in beta cells

人胰岛淀粉样多肽聚集上调β细胞中线粒体胆固醇转运蛋白StAR并诱导线粒体功能障碍

2026-05-200
OAAI
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial

Semaglutide对高危肝纤维化患者的肝纤维化和心脏结局的影响: 一项选择性随机试验的预设分析

2026-04-020
OAAI
Outcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure treated with tirzepatide or dulaglutide: SURPASS-CVOT analysis

糖尿病、动脉粥样硬化性心血管疾病和心力衰竭患者接受替尔泊肽或杜拉格鲁肽治疗的结果:SURPASS-CVOT分析

2026-01-010
OA
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes

在2型糖尿病中,替西帕肽与度拉糖肽的心血管结局比较

2025-12-1812
PRE
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial

司美格鲁肽和心血管结局与基线及体脂测量值变化的关系:SELECT试验的预先指定分析

2025-10-220
OAAI
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial

长期生活方式和二甲双胍干预措施对美国糖尿病预防计划随机临床试验中21年内2型糖尿病发病率的影响及影响异质性

2025-04-280
PRE
Semaglutide and cardiovascular outcomes by blood pressure in the SELECT trial

司美格鲁肽及根据血压的心血管结局:SELECT试验

2024-11-120
PRE
The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity

胰岛组织纤溶酶原激活物/纤溶酶系统被人胰岛淀粉样多肽聚集上调,并保护 β 细胞免受聚集诱导的毒性

2024-09-090
OAAI
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
LANCET
IF88.5
2024-09-019
PRE